NDA 208418 · Fresenius Kabi USA
Calcium Gluconate
Calcium Gluconate · Intravenous
Last checked: Nov 20, 2026Latest source record: Oct 17, 2022 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2017
Jun 15, 2017
Approved uses
1
Original approval plus efficacy supplements
Registered trials
404
89 Phase 3, 25 recruiting
FAERS reports
12,181
10,040 serious, 2,619 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect May 18, 2026.
Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Calcium Gluconate Injection is a form of calcium indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. ( 1 ) Limitations of Use: The safety of Calcium Gluconate Injection for long term use has not been established. ( 1 ) Limitations of Use The safety of Calcium Gluconate Injection for long term use has not been established.
Mechanism: Intravenous administration of calcium gluconate increases serum ionized calcium level. Calcium gluconate dissociates into ionized calcium in plasma. Ionized calcium and gluconate are normal constituents of body fluids.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 15, 2017 Original approval · Type 7 - Drug Already Marketed without Approved NDA LabelLetterPediatric Medical Review
5 products under this application
- CALCIUM GLUCONATE · CALCIUM GLUCONATE 10GM/100ML (100MG/ML) · SOLUTION, INTRAVENOUS · Prescription · TE AP
- CALCIUM GLUCONATE · CALCIUM GLUCONATE 1GM/10ML (100MG/ML) · SOLUTION, INTRAVENOUS · Prescription · TE AP
- CALCIUM GLUCONATE IN SODIUM CHLORIDE · CALCIUM GLUCONATE 1GM/50ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION, INTRAVENOUS · Discontinued · TE AP
- CALCIUM GLUCONATE · CALCIUM GLUCONATE 5GM/50ML (100MG/ML) · SOLUTION, INTRAVENOUS · Prescription · TE AP
- CALCIUM GLUCONATE IN SODIUM CHLORIDE · CALCIUM GLUCONATE 2GM/100ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION, INTRAVENOUS · Discontinued · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Gluconate" as an intervention, any sponsor and status, largest first.
- Zambia Chlorhexidine Application TrialPivotal-lookingCompleted
Boston UniversityAcademic, hospital or other
NCT01241318 · 77,535 participants · Start Feb 2011 · Primary completion Sep 2013
Drug: Chlorhexidine gluconate (4%) · For: Sepsis
Sites: Choma, Zambia
- Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military TraineesPivotal-lookingCompleted
Henry M. Jackson Foundation for the Advancement of Military MedicineAcademic, hospital or other
NCT01105767 · 30,209 participants · Start May 2010 · Primary completion Jan 2012
Drug: Chlorhexidine gluconate · For: Staphylococcus Aureus; MRSA Skin Infections; Staphylococcal Skin Infections
Sites: Columbus, Georgia
VA Office of Research and DevelopmentFederal agency
NCT02216227 · 23,005 participants · Start Apr 1, 2014 · Primary completion Feb 28, 2021
Drug: Mupirocin; Chlorhexidine gluconate and 3 more · For: Surgical Site Infection
Sites: Miami, Florida; Iowa City, Iowa; Baltimore, Maryland · 11 sites in all
- Infection Prophylaxis in Total Joint ReplacementPivotal-lookingRecruiting
Hamilton Health Sciences CorporationAcademic, hospital or other
NCT06126614 · 21,006 participants (planned) · Start May 7, 2024 · Primary completion Nov 2028
Drug: Chlorhexidine Gluconate; Vancomycin Hydrochloride · For: Periprosthetic Joint Infection
Sites: Hamilton, Canada
- Project PROTECT: Protecting Nursing Homes From Infections and HospitalizationPivotal-lookingCompleted
University of California, IrvineAcademic, hospital or other
NCT03118232 · 13,952 participants · Start Apr 3, 2017 · Primary completion Oct 10, 2023
Drug: Chlorhexidine gluconate (CHG); Iodophor (10% povidone-iodine) · For: Hospitalization; Infection
Sites: Anaheim, California; Bellflower, California; Capistrano Beach, California · 28 sites in all
- Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal SurgeryPivotal-lookingCompleted
University of BirminghamAcademic, hospital or other
NCT04256798 · 11,668 participants · Start Nov 13, 2020 · Primary completion Aug 19, 2026
Drug: Chlorhexidine mouthwash; Oxygen and 1 more · For: Infection; Pneumonia; Surgical Site Infection and 9 more
Sites: Botucatu, Brazil; Porto Alegre, Brazil; Salvador, Brazil · 38 sites in all
Boston UniversityAcademic, hospital or other
NCT02386592 · 9,410 participants · Start Sep 1, 2015 · Primary completion Apr 15, 2017
Drug: Chlorhexidine gluconate (CHG) · For: Neonatal Sepsis; Neonatal Mortality
Sites: Lusaka, Zambia
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in SepsisPivotal-lookingCompleted
Children's Hospital of PhiladelphiaAcademic, hospital or other
NCT04102371 · 9,041 participants · Start Aug 25, 2020 · Primary completion Dec 1, 2025
Drug: Lactated Ringer; Normal Saline and 1 more · For: Shock; Septic
Sites: Davis, California; Los Angeles, California; San Francisco, California · 22 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective2,241
- pain1,748
- fatigue1,724
- off label use1,670
- rheumatoid arthritis1,435
- nausea1,420
- alopecia1,369
- vomiting1,331
- pemphigus1,301
- arthropathy1,290
- abdominal discomfort1,284
- psoriatic arthropathy1,283
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 223 |
| 2005 | 2,287 |
| 2006 | 1,041 |
| 2007 | 89 |
| 2008 | 283 |
| 2009 | 112 |
| 2010 | 104 |
| 2011 | 124 |
| 2012 | 178 |
| 2013 | 170 |
| 2014 | 163 |
| 2015 | 203 |
| 2016 | 258 |
| 2017 | 335 |
| 2018 | 393 |
| 2019 | 543 |
| 2020 | 688 |
| 2021 | 702 |
| 2022 | 936 |
| 2023 | 900 |
| 2024 | 874 |
| 2025 | 1,059 |
| 2026 | 516 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Part D: Calcium Gluconate (Calcium Gluconate)
2024 spending
$62K
Beneficiaries
64
681 claims
Per beneficiary
$964
$0.47 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $41,454 |
| 2021 | $84,407 |
| 2022 | $86,574 |
| 2023 | $67,336 |
| 2024 | $61,699 |
Part B: Calcium Gluconate* (Calcium Gluconate*) · HCPCS J0612
2024 spending
$201K
Beneficiaries
11,987
25,471 claims
Per beneficiary
$17
2024 ASP limit $0.04 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $18,423 |
| 2024 | $201,493 |
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.
Boullata JI, Gilbert K, Sacks G, et al. · JPEN J Parenter Enteral Nutr 2014 · Practice Guideline, Systematic Review
- Povidone Iodine vs Chlorhexidine Gluconate in Alcohol for Preoperative Skin Antisepsis: A Randomized Clinical Trial.
Widmer AF, Atkinson A, Kuster SP, et al. · JAMA 2024 · Comparative Study, Equivalence Trial
- Bathing with wipes impregnated with chlorhexidine gluconate to prevent central line-associated bloodstream infection in critically ill patients: A systematic review with meta-analysis.
Peixoto EAC, Poveda VB, Gnatta JR, et al. · Am J Infect Control 2024 · Systematic Review, Meta-Analysis
- The effectiveness of dressings and securement devices to prevent central venous catheter-associated complications: A systematic review and meta-analysis.
Xu H, Hyun A, Mihala G, et al. · Int J Nurs Stud 2024 · Meta-Analysis, Systematic Review
- Improving central venous catheter care with chlorhexidine gluconate dressings: evidence from a systematic review and Meta-analysis.
Xu H, Zhu M, Xu S, et al. · J Health Popul Nutr 2024 · Systematic Review, Meta-Analysis
- The Comparative Efficacy of Chlorhexidine Gluconate and Povidone-iodine Antiseptics for the Prevention of Infection in Clean Surgery: A Systematic Review and Network Meta-analysis.
Wade RG, Burr NE, McCauley G, et al. · Ann Surg 2021 · Comparative Study, Research Support, Non-U.S. Gov't
Sponsor: Fresenius Kabi USA · Also marketed as Calcium Gluconate In Sodium Chloride
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.